Dr. Leon Ferre and his colleagues at Mayo Clinic are conducting medical trials of specific therapies for triple-damaging breast cancer. "We're focusing on tips on how to identify sufferers that will do nicely with less or no chemotherapy. Each individual has some overlap with proteinase